SOURCE: Iconis Bioceuticals

Iconis Bioceuticals

April 12, 2016 08:32 ET

Iconis Bioceuticals' Migra Zero Now Available for Purchase on

Migraine Relief Products Now Widely Available Thanks to Partnership With Major Online Retailer

BOCA RATON, FL--(Marketwired - April 12, 2016) - Iconis Bioceuticals, a company dedicated to developing products that help people to live a healthier, more confident lifestyle, announced its Migra Zero product is now available for sale on, the world's largest online retailer.

The company was founded by Shellie Crossett MSN, a nurse practitioner who has long had an interest and passion for innovative medicine practices. Migra Zero is one of the company's most highly regarded options and was inspired by Crossett's many years of helping people treat their severe headaches through nutraceuticals.

"We are happy to announce that Migra Zero is now available for sale on," Crossett said. "This is a major stepping stone for our company, as Amazon is far and away the most widely used platform for online purchases of all types of products. Now we will be able to reach out to more people than ever before to help them live their lives without having to worry about debilitating headaches."

Migra Zero is particularly unique in that it is an all-natural formula for migraine prevention and defense. The product helps alleviate the intensity of migraines and reduce their frequency. In some cases, it can even help users to completely avoid them. It features four main ingredients: riboflavin, CoEnzyme Q10, magnesium glycinate and butterbur extract, all of which have been proven through in-depth research to be effective treatments against severe headache symptoms. Users take four capsules a day (two each in the morning and night) with water and food.

Migraines a pervasive issue in the United States, with almost one in four American households including someone who has or will have a migraine. Overall, more than 12 percent of the population suffers from migraines. This is a particularly common problem for women, with 18 percent of American women experiencing them (compared to only six percent of men). However, many of the most common treatments for migraines have unwelcome side effects. Iconis Bioceuticals has developed a high-quality, all-natural treatment in response to concerns about those side effects.

"Regular migraines can really have a major, negative impact on a person's life, but they are a problem that can be resolved," said Crossett. "We are making Migra Zero more widely available than ever, which will help us continue to further our mission of helping all people live happier lives."

For more information about Iconis Bioceuticals and its products, visit the company's website at

Contact Information